On March 6, 2009, Bacchus Vascular, Inc. was acquired by Covidien, a $10 billion global healthcare products company. Bacchus Vascular will continue to operate from its headquarters in Santa Clara, CA. Bacchus is dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. |
